from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3427c/-

LFCtreatmentdescriptionclass of inhibitor

-0.433

Amikacinug/mL Amikacintranslation

-0.668

Cap5-10ug/mL Capreomycintranslation

-0.912

Rox10-50 ug/mL Roxithromycintranslation

-0.431

SM2-5 ug/mL Streptomycintranslation

-0.848

Tet5-10 ug/mL Tetracyclinetranslation

0.227

Rif0.2-5ug/mL Rifampicintranscription

1.147

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.648

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.493

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.457

CPZ10-50 ug/mL Chlorpromazinerespiration

0.357

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.473

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.854

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.489

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.310

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.455

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.707

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.467

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.715

KCN5-20 ug/mL Potassium cyaniderespiration

-0.601

NaN30.2-2 mM Sodium aziderespiration

-0.225

Nigericin50 uM Nigericinrespiration

0.473

TRC10-150 ug/mL Triclosanrespiration

0.889

TRZ10-25 ug/mL Thioridazinerespiration

1.681

Valinomycin0.5-10 uM Valinomycinrespiration

-1.283

ZnSO42 mM ZnSO4respiration

0.036

menadione6-10 ug/mL Menadionerespiration

-0.057

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.370

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.268

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.547

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.063

NRP_1Non-replicating persistence stage 1dosRassociated

-0.050

Amp0.2mg/mL AmpicillincellWall

-0.687

Cephalexin20-100 ug/mL CephalexincellWall

-0.336

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.883

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.353

EMB10-20 ug/mL EthambutolcellWall

-0.887

Eta12-40 ug/mL EthionamidecellWall

-1.446

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.110

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.300

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.690

BZA0.12 mg/mL BenzamidearomaticAmides

0.182

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.273

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.257

H2O24 mM hydrogen peroxideDNAdamaging

0.085

Levo10 ug/mL LevofloxacinDNAdamaging

-0.246

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.436

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.087

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.692

UVUV-irradiationDNAdamaging

0.543

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.281

Antimycin12.5-50 ug/mL Antimycin A?

-0.150

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.346

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.389

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.490

PA8240.2-2 ug/mL PA-824?

0.801

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.252

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.367

Verapamil50 uM Verapamil?

0.533

mercaptoethanol2 mM 2-Mercaptoethanol?

0.268

methoxatin10-20 ug/mL Methoxatin?